-
21
-
22“…Regular treatment of DKA patients is not feasible in cases associated with Uremia because of being urineless and prone to heart failure of these patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
23“…Ureaplasma species harbor highly active ureases, and postoperative LTRs commonly experience uremia. We hypothesized that uremia could be a potentiating comorbidity, providing increased substrate for ureaplasmal ureases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24
-
25
-
26por Lyu, Dongning, He, Guangyu, Zhou, Kan, Xu, Jin, Zeng, Haifei, Li, Tongyu, Tang, Ningbo“…PURPOSE: Uremia, which is characterized by immunodeficiency, is associated with the deterioration of kidney function. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
27por Petrov, Maxim N., Shilo, Valery Y., Tarasov, Alexandr V., Schwartz, David E., Garcia, Joe G. N., Kost, Olga A., Danilov, Sergei M.“…HYPOTHESIS: Toxic substances in the blood of patients with uremia due to End Stage Renal Disease (ESRD) can induce local conformational changes in the ACE protein globule and alter the efficacy of ACE inhibitors. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
28por Scherer, Andreas, Günther, Oliver P, Balshaw, Robert F, Hollander, Zsuzsanna, Wilson-McManus, Janet, Ng, Raymond, McMaster, W Robert, McManus, Bruce M, Keown, Paul A“…BACKGROUND: End-stage renal failure is associated with profound changes in physiology and health, but the molecular causation of these pleomorphic effects termed “uremia” is poorly understood. The genomic changes of uremia were explored in a whole genome microarray case-control comparison of 95 subjects with end-stage renal failure (n = 75) or healthy controls (n = 20). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
29por Aarup, Annemarie, Nielsen, Carsten H., Bisgaard, Line S., Bot, Ilze, El-Ali, Henrik H., Kjaer, Andreas, Nielsen, Lars B., Pedersen, Tanja X.“…Atherosclerotic cardiovascular disease is a major complication of chronic kidney disease (CKD). CKD leads to uremia, which modulates the phenotype of aortic smooth muscle cells (SMCs). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
30por Rao, Abhijith Rajaram, Kumar, Pramod, Gunasekaran, Venugopalan, Dey, Aparajit BallavEnlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
31por Panpetch, Wimonrat, Kullapanich, Chitrasak, Dang, Cong Phi, Visitchanakun, Peerapat, Saisorn, Wilasinee, Wongphoom, Jutamas, Wannigama, Dhammika Leshan, Thim-uam, Arthid, Patarakul, Kanitha, Somboonna, Naraporn, Tumwasorn, Somying, Leelahavanichkul, Asada“…The impact of gut fungi and (1→3)-β-d-glucan (BG), a major fungal cell wall component, on uremia was explored by Candida albicans oral administration in bilateral nephrectomy (BiNx) mice because of the prominence of C. albicans in the human intestine but not in mice. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
32“…Cryoprecipitate is frequently administered as treatment for hemostatic defects in patients with uremia. The only published data supporting this approach however, involves seven patients described by Janson and colleagues in whom bleeding times were shortened and bleeding complications reduced after cryoprecipitate infusion. …”
Enlace del recurso
Enlace del recurso
Texto -
33
-
34
-
35
-
36por Walter, Sarah, Baruch, Amos, Alexander, Shawn T, Janes, Julie, Sho, Eiketsu, Dong, Jin, Yin, Qun, Maclean, Derek, Mendel, Dirk B, Karim, Felix, Johnson, Randolph M“…This report describes the activity of AMG 416 in two different rodent models of uremia, compared in each case to cinacalcet, an approved therapeutic for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease on dialysis. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37por Kalim, Sahir, Clish, Clary B., Deferio, Joseph J., Ortiz, Guillermo, Moffet, Alexander S., Gerszten, Robert E., Thadhani, Ravi, Rhee, Eugene P.“…BACKGROUND: Although metabolomic approaches have begun to document numerous changes that arise in end stage renal disease (ESRD), how these alterations relate to established metabolic phenotypes in uremia is unknown. METHODS: In 200 incident hemodialysis patients we used partial least squares discriminant analysis to identify which among 166 metabolites could best discriminate individuals with or without diabetes, and across tertiles of body mass index, serum albumin, total cholesterol, and systolic blood pressure. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38
-
39por Professor I., Sinescu, M.A., Manu, M., Hârza, B., Şerbănescu, B., Ştefan, V., Cerempei, Dorina, Tacu, Eminee, Kerezsy, Cristina, Bucşa, Liliana, Domnişor, Denise, Daia, Ileana, Constantinescu“…Advanced stage chronic renal failure (CRF) – uremia – represents one of the most severe metabolic “catastrophes” of the organism. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
40por Favretto, Giane, da Cunha, Regiane Stafim, Dalboni, Maria Aparecida, de Oliveira, Rodrigo Bueno, Barreto, Fellype de Carvalho, Massy, Ziad A., Stinghen, Andréa Emilia MarquesEnlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto
